Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC BI-3812 | 2166387-64-8 | 99.3% | 558.03 | 10 MG
Supplier: Medchemexpress LLC HY11138110MM/1ML
BI-3812 is characterized as a potent and selective BCL6 inhibitor, functioning as a chemical probe. Its primary mechanism involves the suppression of the BCL6 BTB domain, demonstrated by an IC50 value of ≤ 3 nM. This inhibitory action contributes to its observed antitumor activity. The compound also shows an IC50 of 40 nM for cellular BCL6. It is available for research use only and was developed by Boehringer Ingelheim. Researchers can acquire BI-3812 and its negative control from the open innovation portal, opnMe.com.
- Functions as a chemical probe and highly efficient BCL6 inhibitor
- Suppresses the BTB domain of BCL6
- Has an IC50 value of ≤ 3 nM for BCL6 BTB
- Exhibits antitumor activity
- Has an IC50 of 40 nM for cellular BCL6
- Available for research use only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?